Pacific Biosciences Of California (PACB) Total Debt (QoQ) (2011 - 2023)
Pacific Biosciences Of California (PACB) Total Debt (QoQ) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -99.48% |
| Sep 30, 2023 | -85.09% |
| Jun 30, 2023 | 250.05% |
| Mar 31, 2023 | 5.71% |
| Dec 31, 2018 | 1.91% |
| Sep 30, 2018 | 1.86% |
| Jun 30, 2018 | 1.79% |
| Mar 31, 2018 | 1.74% |
| Dec 31, 2017 | 30.40% |
| Sep 30, 2017 | 0.14% |
| Jun 30, 2017 | -21.51% |
| Mar 31, 2017 | -17.41% |
| Dec 31, 2016 | 1.98% |
| Sep 30, 2016 | 1.92% |
| Jun 30, 2016 | 1.84% |
| Mar 31, 2016 | 1.79% |
| Dec 31, 2015 | 0.95% |
| Sep 30, 2015 | 1.65% |
| Jun 30, 2015 | 1.59% |
| Mar 31, 2015 | 2.49% |